Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT’S
COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Information
Until the completion of an Exchange Listing,
if any, our outstanding Shares will be offered and sold in private offerings exempt from registration under the Securities Act under Section 4(a)(2)
and Regulation D. There is no public market for our Shares currently, nor can we give any assurance that one will develop.
Because Shares are being acquired by investors
in one or more transactions “not involving a public offering,” they are “restricted securities” and may be required
to be held indefinitely. Our Shares may not be sold, transferred, assigned, pledged or otherwise disposed of unless (i) our consent
is granted, and (ii) the Shares are registered under applicable securities laws or specifically exempted from registration (in which
case the stockholder may, at our option, be required to provide us with a legal opinion, in form and substance satisfactory to us, that
registration is not required). Accordingly, an investor must be willing to bear the economic risk of investment in the Shares until we
are liquidated. No sale, transfer, assignment, pledge or other disposition, whether voluntary or involuntary, of the Shares may be made
except by registration of the transfer on our books. Each transferee will be required to execute an instrument agreeing to be bound by
these restrictions and the other restrictions imposed on the Shares and to execute such other instruments or certifications as are reasonably
required by us.
Holders
Please see “Part III—Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” for disclosure regarding the
holders.
As of March 9, 2023, we had 403 holders of
record of our common stock.
Distributions
The following table reflects the distributions
declared and payable for the year ended December 31, 2022 (dollars in thousands, except per share amounts).
Date Declared
Record Date
Payment Date
Dividend
per Share
Total
Dividend
April 19, 2022
April 20, 2022
April 26, 2022
$ 0.26
$ 6,103
July 19, 2022
July 20, 2022
July 27, 2022
0.30
7,065
October 18, 2022
October 13, 2022
October 25, 2022
0.35
10,957
December 16, 2022
December 29, 2022
January 13, 2023
0.43
15,428
$ 1.34
$ 39,553
Dividend Reinvestment Plan
The following table summarizes the amounts received and shares of common
stock issued to shareholders pursuant to our dividend reinvestment plan during the year ended December 31, 2022 (dollars in thousands,
except per share amounts).
Dividend record date
Dividend payment date
DRIP
shares issued
DRIP
value
December 29, 2021
January 18, 2022
55,590
$ 902
April 20, 2022
April 26, 2022
75,270
1,222
July 20, 2022
July 27, 2022
88,081
1,431
October 13, 2022
October 25, 2022
127,414
2,087
346,355
$ 5,642
For the dividend declared on December 16, 2022 and paid on January
13, 2023, there were 57,860 shares issued with a DRIP value of $955. These shares are excluded from the table above, as the DRIP shares
were issued after December 31, 2022.
All of the dividends declared during the year ended December 31, 2022
were derived from ordinary income, determined on a tax basis.
52
Recent Sales of Unregistered Securities
As set forth in the table below (dollars in
thousands, except per share amounts), during the year ended December 31, 2022, we issued and sold 16,305,034 shares of common stock at
an aggregate offering amount of approximately $268.2 million. The issuance of the shares of common stock was exempt from the registration
requirements of the Securities Act, pursuant to Section 4(a)(2) and Rule 506(b) of Regulation D thereof and previously reported by us
on our current reports on Form 8-K.
Common stock issue date
Offering
price per
share
Common stock
shares issued
Aggregate
offering
amount
January 24, 2022
$ 16.36
4,191,292
$ 68,582
July 22, 2022
$ 16.30
7,666,830
$ 125,000
October 31, 2022
$ 16.58
1,485,844
$ 24,636
December 9, 2022
$ 16.89
2,961,068
$ 50,000
Total common stock issued
16,305,034
$ 268,218
ITEM 6. [RESERVED]
The selected financial data previously required
by Item 301 of Regulation S-K has been omitted in reliance on SEC Release No. 33-10890, Management’s Discussion and Analysis, Selected
Financial Data, and Supplementary Financial Information.